NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Kenji Maeda
Kagoshima University - Kagoshima / Japan
Others
AD Scientific Index ID: 5285609
鹿児島大学
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kenji Maeda's MOST POPULAR ARTICLES
1-)
Novel bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human …Y Koh, H Nakata, K Maeda, H Ogata, G Bilcer, T Devasamudram, ...Antimicrobial agents and chemotherapy 47 (10), 3123-3129, 20034602003
2-)
Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variantE Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ...New England Journal of Medicine 386 (10), 995-998, 20223612022
3-)
Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ...New England Journal of Medicine 386 (15), 1475-1477, 20223062022
4-)
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroK Maeda, H Nakata, Y Koh, T Miyakawa, H Ogata, Y Takaoka, ...Journal of virology 78 (16), 8654-8662, 20043042004
5-)
Comparison of rapid antigen tests for COVID-19S Yamayoshi, Y Sakai-Tagawa, M Koga, O Akasaka, I Nakachi, H Koh, ...Viruses 12 (12), 1420, 20202452020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept